Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Army
Cipla
Colorcon
Boehringer Ingelheim
McKesson
Cantor Fitzgerald
Julphar
Chinese Patent Office

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SOYBEAN OIL

« Back to Dashboard

Clinical Trials for Soybean Oil

Trial ID Title Status Sponsor Phase Summary
NCT00028548 XK469 in Treating Patients With Advanced Solid Tumors Completed National Cancer Institute (NCI) Phase 1 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of XK469 in treating patients who have advanced solid tumors.
NCT00028548 XK469 in Treating Patients With Advanced Solid Tumors Completed Barbara Ann Karmanos Cancer Institute Phase 1 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of XK469 in treating patients who have advanced solid tumors.
NCT00179556 Effects of Soy Isoflavones on Menopausal Hot Flashes Completed Nichimo - Tokyo, Japan Phase 2/Phase 3 Hot flashes occur in three quarters of menopausal women, and can negatively impact quality of life. Interest has arisen in isoflavones, found in rich supply in soy products, as therapy for hot flashes. The study examines the effect of a new soy supplement, as compared to a placebo, in menopausal women on hot flash symptoms.
NCT00179556 Effects of Soy Isoflavones on Menopausal Hot Flashes Completed Beth Israel Deaconess Medical Center Phase 2/Phase 3 Hot flashes occur in three quarters of menopausal women, and can negatively impact quality of life. Interest has arisen in isoflavones, found in rich supply in soy products, as therapy for hot flashes. The study examines the effect of a new soy supplement, as compared to a placebo, in menopausal women on hot flash symptoms.
NCT00211848 Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers Unknown status Hoffmann-La Roche Phase 2 The primary aim of this investigation is to evaluate the effect of a combined antiviral, antifibrotic and antioxidant treatment on the progression of liver disease in patients with hepatitis C who either abstain from alcohol or continue to drink. All subjects are given state-of-the-art antiviral treatment (pegylated interferon + ribavirin), supplemented with either placebo or polyenylphosphatidylcholine (PPC), a purified soybean extract consisting of 95-96% polyunsaturated phosphatidylcholines (PC) and which has both antifibrotic and antioxidant properties. Secondary aims are to verify whether moderate alcohol consumption interferes with the antiviral effect of pegylated interferon + ribavirin on HCV and to validate the reliability of various circulating markers as substitute for liver biopsies to indicate the stage of liver pathology and its propensity for progression.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Soybean Oil

Condition Name

Condition Name for Soybean Oil
Intervention Trials
Cholestasis 10
Total Parenteral Nutrition-induced Cholestasis 4
Myelodysplastic Syndrome 2
Short Bowel Syndrome 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Soybean Oil
Intervention Trials
Cholestasis 13
Liver Diseases 7
Premature Birth 3
Short Bowel Syndrome 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Soybean Oil

Trials by Country

Trials by Country for Soybean Oil
Location Trials
United States 44
Spain 8
Canada 4
China 4
France 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Soybean Oil
Location Trials
New York 6
California 4
Pennsylvania 3
Georgia 3
North Carolina 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Soybean Oil

Clinical Trial Phase

Clinical Trial Phase for Soybean Oil
Clinical Trial Phase Trials
Phase 4 17
Phase 3 9
Phase 2/Phase 3 4
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Soybean Oil
Clinical Trial Phase Trials
Completed 18
Unknown status 10
Recruiting 9
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Soybean Oil

Sponsor Name

Sponsor Name for Soybean Oil
Sponsor Trials
Baxter Healthcare Corporation 3
Emory University 2
Beth Israel Deaconess Medical Center 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Soybean Oil
Sponsor Trials
Other 64
Industry 10
NIH 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKinsey
Johnson and Johnson
Fuji
Cipla
Queensland Health
Federal Trade Commission
Daiichi Sankyo
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.